title: New serological biomarkers of inflammatory bowel disease.
abstract: Serological biomarkers in inflammatory bowel disease (IBD) are a rapidly expanding list of non-invasive tests for objective assessments of disease activity, early diagnosis, prognosis evaluation and surveillance. This review summarizes both old and new biomarkers in IBD, but focuses on the development and characterization of new serological biomarkers (identified since 2007). These include five new anti-glycan antibodies, anti-chitobioside IgA (ACCA), anti-laminaribioside IgG (ALCA), anti-manobioside IgG (AMCA), and antibodies against chemically synthesized (Sigma) two major oligomannose epitopes, Man alpha-1,3 Man alpha-1,2 Man (SigmaMan3) and Man alpha-1,3 Man alpha-1,2 Man alpha-1,2 Man (SigmaMan4). These new biomarkers serve as valuable complementary tools to existing biomarkers not only in differentiating Crohn's disease (CD), ulcerative colitis (UC), normal and other non-IBD gut diseases, but also in predicting disease involvement (ileum vs colon), IBD risk (as subclinical biomarkers), and disease course (risk of complication and surgery). Interestingly, the prevalence of the antiglycan antibodies, including anti-Saccharomyces cerevisiae antibodies (ASCA), ALCA and AMCA, was found to be associated with single nucleotide polymorphisms (SNPs) of IBD susceptible genes such as NOD2/CARD15, NOD1/CARD4, toll-like receptors (TLR) 2 and 4, and beta-defensin-1. Furthermore, a gene dosage effect was observed: anti-glycan positivity became more frequent as the number of NOD2/CARD15 SNPS increased. Other new serum/plasma IBD biomarkers reviewed include ubiquitination factor E4A (UBE4A), CXCL16 (a chemokine), resistin, and apolipoprotein A-IV. This review also discusses the most recent studies in IBD biomarker discovery by the application of new technologies such as proteomics, fourier transform near-infrared spectroscopy, and multiplex enzyme-linked immunosorbent assay (ELISA)'s (with an emphasis on cytokine/chemokine profiling). Finally, the prospects of developing more clinically useful novel diagnostic algorithms by incorporating new technologies in serological biomarker profiling and integrating multiple biomarkers with bioinformatics analysis/modeling are also discussed.
authors.affiliation: Division of Gastroenterology, Department of Medicine, Johns Hopkins University School of Medicine, 720 Rutland Ave, 918 Ross Research Bldg, Baltimore, MD 21205, United States. xuhang@jhmi.edu
authors.forename: Xuhang
authors.initials: X
authors.lastname: Li
authors.forename: Laurie
authors.initials: L
authors.lastname: Conklin
authors.forename: Philip
authors.initials: P
authors.lastname: Alex
mesh_terms: D000888:Antibodies, Anti-Idiotypic / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000097:blood* / Q000175:diagnosis; D011134:Polysaccharides / Q000276:immunology*; D011379:Prognosis
chemical_list: D000888:Antibodies, Anti-Idiotypic; D015415:Biomarkers; D011134:Polysaccharides
references.citation: Gastroenterology. 2006 Aug;131(2):366-78
references.pmid: 16890590
references.citation: Clin Chem. 2006 Feb;52(2):171-81
references.pmid: 16339302
references.citation: Am J Gastroenterol. 2007 Apr;102(4):803-13
references.pmid: 17324124
references.citation: Am J Gastroenterol. 2005 Feb;100(2):414-23
references.pmid: 15667502
references.citation: J Neurol Sci. 2006 May 15;244(1-2):59-68
references.pmid: 16480743
references.citation: Gut. 2006 Nov;55(11):1667-9
references.pmid: 16687433
references.citation: Am J Gastroenterol. 2008 Jan;103(1):162-9
references.pmid: 17916108
references.citation: World J Gastroenterol. 2008 Jan 21;14(3):338-47
references.pmid: 18200657
references.citation: J Clin Invest. 2004 Jul;114(2):260-9
references.pmid: 15254593
references.citation: Gastroenterology. 2004 Feb;126(2):414-24
references.pmid: 14762777
references.citation: Am J Gastroenterol. 2004 Nov;99(11):2186-94
references.pmid: 15555001
references.citation: Annu Rev Med. 2000;51:289-98
references.pmid: 10774465
references.citation: Biochem Pharmacol. 2007 May 1;73(9):1422-33
references.pmid: 17258689
references.citation: Radiographics. 2004 Jan-Feb;24(1):e18
references.pmid: 14527992
references.citation: Inflamm Bowel Dis. 2008 Mar;14(3):310-7
references.pmid: 18069675
references.citation: Am J Gastroenterol. 2006 Oct;101(10):2410-22
references.pmid: 16952282
references.citation: Inflamm Bowel Dis. 2007 Apr;13(4):391-7
references.pmid: 17206692
references.citation: Curr Gastroenterol Rep. 2007 Dec;9(6):489-96
references.pmid: 18377802
references.citation: J Immunol. 2005 May 1;174(9):5789-95
references.pmid: 15843582
references.citation: Inflamm Bowel Dis. 2009 Mar;15(3):341-52
references.pmid: 18942757
references.citation: Dig Liver Dis. 2007 Dec;39(12):1064-70
references.pmid: 17964870
references.citation: Gut. 2007 Nov;56(11):1536-42
references.pmid: 17595233
references.citation: Expert Opin Ther Targets. 2008 May;12(5):553-63
references.pmid: 18410239
references.citation: Tissue Antigens. 2008 Jun;71(6):552-9
references.pmid: 18397186
references.citation: Scand J Gastroenterol. 2001 Feb;36(2):196-201
references.pmid: 11252413
references.citation: Inflamm Bowel Dis. 2007 Dec;13(12):1561-6
references.pmid: 17636565
references.citation: Gastroenterology. 2007 Feb;132(2):576-86
references.pmid: 17258734
references.citation: Am J Gastroenterol. 2008 Apr;103(4):949-57
references.pmid: 18047546
references.citation: Scand J Gastroenterol. 2008 Mar;43(3):283-8
references.pmid: 18938659
references.citation: Inflamm Bowel Dis. 2007 May;13(5):524-30
references.pmid: 17260364
references.citation: Gut. 2005 Sep;54(9):1232-6
references.pmid: 16099791
references.citation: J Med Genet. 2008 Jan;45(1):36-42
references.pmid: 17693570
references.citation: Eur J Gastroenterol Hepatol. 2003 Dec;15(12):1281-5
references.pmid: 14624150
references.citation: Clin Adv Hematol Oncol. 2006 Jul;4(7):541-9
references.pmid: 17147241
references.citation: Am J Gastroenterol. 2007 Sep;102(9):2058-69
references.pmid: 17561966
references.citation: Am J Gastroenterol. 2004 Dec;99(12):2376-84
references.pmid: 15571586
references.citation: Inflamm Bowel Dis. 1998 Feb;4(1):18-26
references.pmid: 9552224
references.citation: Aliment Pharmacol Ther. 2007 Feb 1;25(3):247-55
references.pmid: 17217454
references.citation: Inflamm Bowel Dis. 2009 Apr;15(4):616-29
references.pmid: 18844215
references.citation: Inflamm Bowel Dis. 2007 Aug;13(8):975-83
references.pmid: 17427244
references.citation: Med Klin (Munich). 2000 Apr 15;95(4):201-6
references.pmid: 10808301
references.citation: Dis Colon Rectum. 2007 Oct;50(10):1697-706
references.pmid: 17762964
references.citation: Top Magn Reson Imaging. 2002 Dec;13(6):409-25
references.pmid: 12478021
references.citation: Am J Gastroenterol. 2004 Jul;99(7):1371-85
references.pmid: 15233681
references.citation: Inflamm Bowel Dis. 2006 Dec;12(12):1122-30
references.pmid: 17119386
references.citation: Glycobiology. 2003 Nov;13(11):749-54
references.pmid: 12851287
references.citation: Nature. 2008 Apr 3;452(7187):571-9
references.pmid: 18385731
references.citation: World J Gastroenterol. 2007 Apr 14;13(14):2028-36
references.pmid: 17465443
references.citation: Arch Immunol Ther Exp (Warsz). 1998;46(3):143-55
references.pmid: 9704146
references.citation: Clin Biochem. 2008 Aug;41(12):960-7
references.pmid: 18489908
references.citation: Inflamm Bowel Dis. 2006 Jun;12(6):524-34
references.pmid: 16775498
references.citation: Am J Gastroenterol. 1998 Aug;93(8):1306-10
references.pmid: 9707056
references.citation: Biosci Biotechnol Biochem. 2005 Mar;69(3):553-8
references.pmid: 15784984
references.citation: Eur J Gastroenterol Hepatol. 2007 Dec;19(12):1070-4
references.pmid: 17998831
references.citation: Gut. 2006 Mar;55(3):342-7
references.pmid: 16000642
references.citation: Gut. 2007 Oct;56(10):1394-403
references.pmid: 17456509
references.citation: Clin Exp Rheumatol. 2007 Jul-Aug;25(4):584-92
references.pmid: 17888215
references.citation: Expert Rev Mol Diagn. 2008 May;8(3):327-37
references.pmid: 18598111
references.citation: Electrophoresis. 2007 Dec;28(23):4261-73
references.pmid: 17979160
references.citation: Rapid Commun Mass Spectrom. 2007;21(24):4142-8
references.pmid: 18022963
references.citation: Rheumatology (Oxford). 2007 Mar;46(3):417-25
references.pmid: 16936328
references.citation: Gastroenterology. 2002 Sep;123(3):679-88
references.pmid: 12198692
references.citation: Am J Gastroenterol. 2001 Feb;96(2):449-54
references.pmid: 11232689
references.citation: Inflamm Bowel Dis. 2007 Aug;13(8):984-92
references.pmid: 17417801
references.citation: Gut. 1998 Jun;42(6):788-91
references.pmid: 9691915
references.citation: Inflamm Bowel Dis. 2004 May;10(3):229-33
references.pmid: 15290916
references.citation: Annu Rev Pathol. 2008;3:485-98
references.pmid: 18039142
references.citation: Dig Dis Sci. 2004 Aug;49(7-8):1265-74
references.pmid: 15387356
references.citation: J Immunol. 2004 Mar 15;172(6):3678-85
references.pmid: 15004171
references.citation: Gut. 2006 Mar;55(3):426-31
references.pmid: 16474109
references.citation: Gastroenterology. 2007 Nov;133(5):1670-89
references.pmid: 17983810
references.citation: Inflamm Bowel Dis. 2007 Mar;13(3):338-55
references.pmid: 17206667
references.citation: Inflamm Bowel Dis. 2008 May;14(5):645-51
references.pmid: 18240283
references.citation: Am J Gastroenterol. 2006 Feb;101(2):360-7
references.pmid: 16454844
references.citation: Dis Markers. 2007;23(5-6):411-7
references.pmid: 18057524
references.citation: Lupus. 2006;15(7):442-50
references.pmid: 16898180
references.citation: Am J Gastroenterol. 2001 Mar;96(3):730-4
references.pmid: 11280542
references.citation: Am J Gastroenterol. 2008 Mar;103(3):665-81
references.pmid: 18047543
references.citation: J Gastroenterol. 2003;38(2):121-6
references.pmid: 12640524